LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 152

Suchoptionen

  1. Artikel: An outreach activity to enhance biochemistry pedagogy.

    Roth, Karl S / Bannerman, Tammy / Gopalan, Venkat

    Trends in biochemical sciences

    2023  Band 48, Heft 5, Seite(n) 410–413

    Abstract: Students are self-motivated to learn when provided opportunities that connect theory and real-world applications. Here, we describe for biochemistry majors a newborn screening-focused outreach activity that seeks to develop students' mastery of ... ...

    Abstract Students are self-motivated to learn when provided opportunities that connect theory and real-world applications. Here, we describe for biochemistry majors a newborn screening-focused outreach activity that seeks to develop students' mastery of disciplinary content and soft skills (e.g., critical thinking, teamwork, effective communication, community engagement) and to enhance student engagement.
    Mesh-Begriff(e) Humans ; Biochemistry/education ; Students
    Sprache Englisch
    Erscheinungsdatum 2023-03-14
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 194216-5
    ISSN 1362-4326 ; 0968-0004 ; 0376-5067
    ISSN (online) 1362-4326
    ISSN 0968-0004 ; 0376-5067
    DOI 10.1016/j.tibs.2023.02.003
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cure.

    Pottenger, Ayumi E / Roy, Debashish / Srinivasan, Selvi / Chavas, Thomas E J / Vlaskin, Vladmir / Ho, Duy-Khiet / Livingston, Vincent C / Maktabi, Mahdi / Lin, Hsiuling / Zhang, Jing / Pybus, Brandon / Kudyba, Karl / Roth, Alison / Senter, Peter / Tyson, George / Huber, Hans E / Wesche, David / Rochford, Rosemary / Burke, Paul A /
    Stayton, Patrick S

    Science advances

    2024  Band 10, Heft 16, Seite(n) eadk4492

    Abstract: Approximately 3.3 billion people live with the threat ... ...

    Abstract Approximately 3.3 billion people live with the threat of
    Mesh-Begriff(e) Humans ; Antimalarials/pharmacology ; Antimalarials/therapeutic use ; Aminoquinolines/adverse effects ; Malaria/drug therapy ; Malaria, Vivax/drug therapy ; Malaria, Vivax/chemically induced ; Liver
    Chemische Substanzen tafenoquine (262P8GS9L9) ; Antimalarials ; Aminoquinolines
    Sprache Englisch
    Erscheinungsdatum 2024-04-19
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.adk4492
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case report.

    Koch, Christian / Fleischer, Juliane / Popov, Todor / Frontzek, Karl / Schreiner, Bettina / Roth, Patrick / Manz, Markus G / Unseld, Simone / Müller, Antonia M S / Russkamp, Norman F

    Journal for immunotherapy of cancer

    2023  Band 11, Heft 1

    Abstract: Background: Immune effector cell-associated neurotoxicity syndrome (ICANS) is a common adverse event of CD19-directed chimeric antigen receptor (CAR) T cell therapy. Other neurological adverse events, however, have not methodically been described and ... ...

    Abstract Background: Immune effector cell-associated neurotoxicity syndrome (ICANS) is a common adverse event of CD19-directed chimeric antigen receptor (CAR) T cell therapy. Other neurological adverse events, however, have not methodically been described and studied. Furthermore, safety data on CAR-T cell therapy in patients with central nervous system (CNS) lymphoma remain limited.
    Main body: We here report occurrence of a Guillain-Barré-like syndrome (GBS) and central diabetes insipidus (cDI) following tisagenlecleucel therapy for relapsed high-grade lymphoma with CNS involvement. Both complications were refractory to standard treatment of ICANS. Weakness of respiratory muscles required mechanical ventilation and tracheostomy while cDI was treated with desmopressin substitution for several weeks. Muscle-nerve biopsy and nerve conduction studies confirmed an axonal pattern of nerve damage. T cell-rich infiltrates and detection of the CAR transgene in muscle-nerve sections imply a direct or indirect role of CAR-T cell-mediated inflammation. In line with current treatment guidelines for GBS, intravenous immunoglobulin was administered and gradual but incomplete recovery was observed over the course of several months.
    Conclusions: This case report highlights the risk of rare but severe neurological adverse events, such as acute GBS or cDI, in patients treated with CAR-T cells. It further underlines the importance of appropriate patient surveillance and systematic reporting of rare complications to eventually improve treatment.
    Mesh-Begriff(e) Humans ; Receptors, Chimeric Antigen ; Immunotherapy, Adoptive/adverse effects ; Lymphoma, Non-Hodgkin ; Central Nervous System Neoplasms ; Diabetes Insipidus/etiology ; Cell- and Tissue-Based Therapy ; Diabetes Mellitus
    Chemische Substanzen Receptors, Chimeric Antigen ; cell-associated neurotoxicity
    Sprache Englisch
    Erscheinungsdatum 2023-01-23
    Erscheinungsland England
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 2719863-7
    ISSN 2051-1426 ; 2051-1426
    ISSN (online) 2051-1426
    ISSN 2051-1426
    DOI 10.1136/jitc-2022-006059
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Buch: Biochemistry and disease

    Cohn, Robert M. / Roth, Karl S.

    bridging basic science and clinical practice

    1996  

    Verfasserangabe Robert M. Cohn ; Karl S. Roth
    Schlagwörter Medicine ; Biochemistry ; Metabolic Diseases
    Sprache Englisch
    Umfang XIV, 587 S. : graph. Darst.
    Verlag Williams & Wilkins
    Erscheinungsort Baltimore u.a.
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT007558033
    ISBN 0-683-02049-8 ; 978-0-683-02049-6
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Kategorien

  5. Artikel: Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2

    Eastman, Richard T / Rusinova, Radda / Herold, Karl F / Huang, Xi-Ping / Dranchak, Patricia / Voss, Ty C / Rana, Sandeep / Shrimp, Jonathan H / White, Alex D / Hemmings, Hugh C / Roth, Bryan L / Inglese, James / Andersen, Olaf S / Dahlin, Jayme L

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Since it was proposed as a potential host-directed antiviral agent for SARS-CoV-2, the antiparasitic drug ivermectin has been investigated thoroughly in clinical trials, which have provided insufficient support for its clinical efficacy. To examine the ... ...

    Abstract Since it was proposed as a potential host-directed antiviral agent for SARS-CoV-2, the antiparasitic drug ivermectin has been investigated thoroughly in clinical trials, which have provided insufficient support for its clinical efficacy. To examine the potential for ivermectin to be repurposed as an antiviral agent, we therefore undertook a series of preclinical studies. Consistent with early reports, ivermectin decreased SARS-CoV-2 viral burden in
    Sprache Englisch
    Erscheinungsdatum 2023-10-24
    Erscheinungsland United States
    Dokumenttyp Preprint
    DOI 10.1101/2023.10.23.563088
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Buch: Pediatric endocrinology and inborn errors of metabolism

    Sarafoglou, Kyriakie / Hoffmann, Georg F / Roth, Karl S

    2017  

    Verfasserangabe editor, Kyriakie Sarafoglou ; associate editors, Georg F. Hoffmann, Karl S. Roth
    Mesh-Begriff(e) Endocrine System Diseases ; Child ; Metabolism, Inborn Errors ; Infant
    Sprache Englisch
    Umfang p. ;, cm.
    Ausgabenhinweis Second edition.
    Dokumenttyp Buch
    ISBN 9780071773140 ; 0071773142
    Datenquelle Katalog der US National Library of Medicine (NLM)

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Concurrent isolation of hepatic stem cells and hepatocytes from the human liver.

    Lee, Serene M L / Bertinetti-Lapatki, Cristina / Schiergens, Tobias S / Jauch, Karl-Walter / Roth, Adrian B / Thasler, Wolfgang E

    In vitro cellular & developmental biology. Animal

    2020  Band 56, Heft 3, Seite(n) 253–260

    Abstract: Hepatocytes differentiated from induced pluripotent stem cells or stem cells have the potential to be representative in vitro models of the human liver for research as well as early safety assessment programs. However, up until now, there has been no ... ...

    Abstract Hepatocytes differentiated from induced pluripotent stem cells or stem cells have the potential to be representative in vitro models of the human liver for research as well as early safety assessment programs. However, up until now, there has been no definitive proof that differentiated hepatocytes recapitulate the phenotype and functional characteristics of primary hepatocytes from the same individual. Thus, a method for the concurrent isolation of hepatocytes and hepatic stem cells is presented here to provide the cells necessary for the evaluation of the required benchmarking. The method presented here generated high-quality hepatocytes with a purity of 94 ± 1% and a high percentage viability of 79 ± 2%. Furthermore, the hepatic stem cells isolated were found to be actively proliferating and have a purity of 98 ± 1%. Thus, these isolated cells can be used as a powerful tool for the validation of differentiated hepatocyte in vitro models.
    Mesh-Begriff(e) Cell Separation/methods ; Epithelial Cell Adhesion Molecule/metabolism ; Hepatocytes/cytology ; Humans ; Keratin-19/metabolism ; Liver/cytology ; Liver Cirrhosis/pathology ; Stem Cells/cytology ; Stem Cells/metabolism
    Chemische Substanzen Epithelial Cell Adhesion Molecule ; Keratin-19
    Sprache Englisch
    Erscheinungsdatum 2020-03-27
    Erscheinungsland Germany
    Dokumenttyp Journal Article
    ZDB-ID 1077810-x
    ISSN 1543-706X ; 0883-8364 ; 1071-2690
    ISSN (online) 1543-706X
    ISSN 0883-8364 ; 1071-2690
    DOI 10.1007/s11626-020-00433-w
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: The immune response to a Coxiella burnetii vaccine in sheep varies according to their natural pre-exposure.

    Böttcher, Jens / Bauer, Benjamin U / Ambros, Christina / Alex, Michaela / Domes, Ursula / Roth, Sabine / Boll, Kerstin / Korneli, Martin / Bogner, Karl-Heinz / Randt, Andreas / Janowetz, Britta

    Vaccine

    2024  Band 42, Heft 8, Seite(n) 1993–2003

    Abstract: Q fever in humans is caused by Coxiella (C.) burnetii. In 2008 and 2012, cases of Q fever in humans were linked to an infected flock of approximately 650 ewes. Since 2013 gimmers (G'13, G'14, G'15 etc.) were primary vaccinated (two doses) with an ... ...

    Abstract Q fever in humans is caused by Coxiella (C.) burnetii. In 2008 and 2012, cases of Q fever in humans were linked to an infected flock of approximately 650 ewes. Since 2013 gimmers (G'13, G'14, G'15 etc.) were primary vaccinated (two doses) with an inactivated C.burnetii vaccine without any revaccination. In 2013, 30 ewes were primary vaccinated (A'13). Shedding was annually monitored by qPCR-testing of vaginal and nasal swabs collected at lambing. Animals were tested for Phase I- (PhI) and PhII-antibodies (Ab) and for PhII-specific-interferon-γ (IFN-γ) before and after vaccination. The effect of a revaccination was determined in 2018 and 2023. Groups of randomly selected gimmers primary vaccinated in 2015, 2016 and 2017 and a mixed group of older animals (A'13, G'13 and G'14) were revaccinated once in 2018. The trial was repeated in 2023 on groups primary vaccinated in 2019-2023. Major shedding after the outbreak in 2012 ceased in 2014. Thereafter C.burnetii was only sporadically detected at low-level in 2018, 2021 and 2023. Sheep naturally exposed to C.burnetii during the outbreak in 2012 (A'13, G'13) mounted a strong and complete (PhI, PhII, IFN-γ) recall immune response after vaccination. A serological PhI
    Mesh-Begriff(e) Humans ; Sheep ; Animals ; Female ; Coxiella burnetii ; Q Fever/prevention & control ; Q Fever/veterinary ; Q Fever/epidemiology ; Antibodies ; Bacterial Vaccines ; Immunity
    Chemische Substanzen Antibodies ; Bacterial Vaccines
    Sprache Englisch
    Erscheinungsdatum 2024-02-21
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2024.02.048
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity

    Eastman, Richard T / Rusinova, Radda / Herold, Karl F / Huang, Xi-Ping / Dranchak, Patricia / Voss, Ty C / Rana, Sandeep / Shrimp, Jonathan H / White, Alex D / Hemmings, Hugh C / Roth, Bryan L / Inglese, James / Andersen, Olaf S / Dahlin, Jayme L

    bioRxiv

    Abstract: Since it was proposed as a potential host-directed antiviral agent for SARS-CoV-2, the antiparasitic drug ivermectin has been investigated thoroughly in clinical trials, which have provided insufficient support for its clinical efficacy. To examine the ... ...

    Abstract Since it was proposed as a potential host-directed antiviral agent for SARS-CoV-2, the antiparasitic drug ivermectin has been investigated thoroughly in clinical trials, which have provided insufficient support for its clinical efficacy. To examine the potential for ivermectin to be repurposed as an antiviral agent, we therefore undertook a series of preclinical studies. Consistent with early reports, ivermectin decreased SARS-CoV-2 viral burden in in vitro models at low micromolar concentrations, five- to ten-fold higher than the reported toxic clinical concentration. At similar concentrations, ivermectin also decreased cell viability and increased biomarkers of cytotoxicity and apoptosis. Further mechanistic and profiling studies revealed that ivermectin nonspecifically perturbs membrane bilayers at the same concentrations where it decreases the SARS-CoV-2 viral burden, resulting in nonspecific modulation of membrane-based targets such as G-protein coupled receptors and ion channels. These results suggest that a primary molecular mechanism for the in vitro antiviral activity of ivermectin may be nonspecific membrane perturbation, indicating that ivermectin is unlikely to be translatable into a safe and effective antiviral agent. These results and experimental workflow provide a useful paradigm for performing preclinical studies on (pandemic-related) drug repurposing candidates.
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2023-10-24
    Verlag Cold Spring Harbor Laboratory
    Dokumenttyp Artikel ; Online
    DOI 10.1101/2023.10.23.563088
    Datenquelle COVID19

    Kategorien

  10. Artikel: Concurrent isolation of hepatic stem cells and hepatocytes from the human liver

    Lee, Serene M. L / Bertinetti-Lapatki, Cristina / Schiergens, Tobias S / Jauch, Karl-Walter / Roth, Adrian B / Thasler, Wolfgang E

    In vitro cellular & developmental biology. 2020 Mar., v. 56, no. 3

    2020  

    Abstract: Hepatocytes differentiated from induced pluripotent stem cells or stem cells have the potential to be representative in vitro models of the human liver for research as well as early safety assessment programs. However, up until now, there has been no ... ...

    Abstract Hepatocytes differentiated from induced pluripotent stem cells or stem cells have the potential to be representative in vitro models of the human liver for research as well as early safety assessment programs. However, up until now, there has been no definitive proof that differentiated hepatocytes recapitulate the phenotype and functional characteristics of primary hepatocytes from the same individual. Thus, a method for the concurrent isolation of hepatocytes and hepatic stem cells is presented here to provide the cells necessary for the evaluation of the required benchmarking. The method presented here generated high-quality hepatocytes with a purity of 94 ± 1% and a high percentage viability of 79 ± 2%. Furthermore, the hepatic stem cells isolated were found to be actively proliferating and have a purity of 98 ± 1%. Thus, these isolated cells can be used as a powerful tool for the validation of differentiated hepatocyte in vitro models.
    Schlagwörter functional properties ; hepatocytes ; humans ; induced pluripotent stem cells ; liver ; models ; phenotype ; safety assessment ; viability
    Sprache Englisch
    Erscheinungsverlauf 2020-03
    Umfang p. 253-260.
    Erscheinungsort Springer US
    Dokumenttyp Artikel
    ISSN 1071-2690
    DOI 10.1007/s11626-020-00433-w
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang